Kit, composition, and combination therapy for fragile X syndrome
US11590093B2 · kind B2 · utility
0Cited by
2References
11Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 12, 2019 |
| Grant date | Feb 28, 2023 |
| Priority date | — |
| Expiry date | Apr 12, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are kits, compositions, and combination therapies comprising sulindac for use in the treatment of fragile X syndrome (FXS).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.